These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells. Ugarte-Berzal E, Bailón E, Amigo-Jiménez I, Albar JP, García-Marco JA, García-Pardo A. J Biol Chem; 2014 May 30; 289(22):15340-9. PubMed ID: 24739387 [Abstract] [Full Text] [Related]
5. Inhibition of MMP-9-dependent Degradation of Gelatin, but Not Other MMP-9 Substrates, by the MMP-9 Hemopexin Domain Blades 1 and 4. Ugarte-Berzal E, Vandooren J, Bailón E, Opdenakker G, García-Pardo A. J Biol Chem; 2016 May 27; 291(22):11751-60. PubMed ID: 27044750 [Abstract] [Full Text] [Related]
11. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways. Amigo-Jiménez I, Bailón E, Aguilera-Montilla N, Terol MJ, García-Marco JA, García-Pardo A. Oncotarget; 2015 Dec 29; 6(42):44832-48. PubMed ID: 26540567 [Abstract] [Full Text] [Related]
12. Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells. Aguilera-Montilla N, Bailón E, Ugarte-Berzal E, Uceda-Castro R, Prieto-Solano M, García-Martínez E, Samaniego R, Van den Steen PE, Opdenakker G, García-Marco JA, García-Pardo A. Biochem Biophys Res Commun; 2019 Nov 26; 520(1):198-204. PubMed ID: 31585732 [Abstract] [Full Text] [Related]
14. Role of the hemopexin domain of matrix metalloproteinases in cell migration. Dufour A, Sampson NS, Zucker S, Cao J. J Cell Physiol; 2008 Dec 26; 217(3):643-51. PubMed ID: 18636552 [Abstract] [Full Text] [Related]
16. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax. de la Fuente MT, Casanova B, Garcia-Gila M, Silva A, Garcia-Pardo A. Leukemia; 1999 Feb 26; 13(2):266-74. PubMed ID: 10025901 [Abstract] [Full Text] [Related]
18. Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2). Xu X, Mikhailova M, Chen Z, Pal S, Robichaud TK, Lafer EM, Baber S, Steffensen B. Matrix Biol; 2011 Sep 26; 30(7-8):404-12. PubMed ID: 21839835 [Abstract] [Full Text] [Related]
19. Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1. Ries C, Pitsch T, Mentele R, Zahler S, Egea V, Nagase H, Jochum M. Biochem J; 2007 Aug 01; 405(3):547-58. PubMed ID: 17489740 [Abstract] [Full Text] [Related]
20. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. de la Fuente MT, Casanova B, Moyano JV, Garcia-Gila M, Sanz L, Garcia-Marco J, Silva A, Garcia-Pardo A. J Leukoc Biol; 2002 Mar 01; 71(3):495-502. PubMed ID: 11867687 [Abstract] [Full Text] [Related] Page: [Next] [New Search]